A steatotic liver disease characterized by at least one of the five cardiometabolic risk factors for MASLD and alcohol consumption of 140-350g/week (females) or 210-420g/week (males). This disease is ...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning metabolic dysfunction and alcohol associated liver disease
Updated Feb 3, 2026
A new study integrates body composition analysis with machine learning to non-invasively identify metabolic dysfunction-associated fatty liver disease (MAFLD). This large-scale health examination highlights innovative approaches to diagnosing a condition affecting millions.